Insights from systems pharmacology into cardiovascular drug discovery and therapy - Wikidata - awgldk - TriplyDB

Insights from systems pharmacology into cardiovascular drug discovery and therapy

Insights from systems pharmacology into cardiovascular drug discovery and therapy

http://www.wikidata.org/entity/Q34979129

about

Using quantitative systems pharmacology for novel drug discovery.Rosmarinic Acid Protects against Inflammation and Cardiomyocyte Apoptosis during Myocardial Ischemia/Reperfusion Injury by Activating Peroxisome Proliferator-Activated Receptor Gamma Weak-binding molecules are not drugs?-toward a systematic strategy for finding effective weak-binding drugs.Illuminating drug action by network integration of disease genes: a case study of myocardial infarction.Network Pharmacology-Based Validation of Caveolin-1 as a Key Mediator of Ai Du Qing Inhibition of Drug Resistance in Breast Cancer

P2860

Q38578286-9706DED1-184E-451B-86EE-9D398FBF1998 Q38661320-87355CB5-CE4E-44BD-8421-A099CBE5BC28 Q38897226-FE1C49B2-3104-4E2F-A01A-EBF3E56A5E95 Q40672660-AF5C7E6F-8AE9-444A-8CCA-F631924C268D Q58586893-7013CECC-9569-424C-A81D-015F05A851EC

P2860

Insights from systems pharmacology into cardiovascular drug discovery and therapy

http://www.wikidata.org/entity/Q34979129

description

2014 nî lūn-bûn

@nan

2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Insights from systems pharmacology into cardiovascular drug discovery and therapy

@ast

Insights from systems pharmacology into cardiovascular drug discovery and therapy

@en

Insights from systems pharmacology into cardiovascular drug discovery and therapy

@nl

type

label

Insights from systems pharmacology into cardiovascular drug discovery and therapy

@ast

Insights from systems pharmacology into cardiovascular drug discovery and therapy

@en

Insights from systems pharmacology into cardiovascular drug discovery and therapy

@nl

prefLabel

Insights from systems pharmacology into cardiovascular drug discovery and therapy

@ast

Insights from systems pharmacology into cardiovascular drug discovery and therapy

@en

Insights from systems pharmacology into cardiovascular drug discovery and therapy

@nl

P1433

Q34979129-98E58FAB-9B76-4289-9D6C-6846477A6225

P1476

Q34979129-1117BE5C-B220-4DA1-984F-8405642D080C

P2093

Q34979129-08164398-0B8C-41F9-B049-9474AE686A9D

Q34979129-1F97F381-33F9-43D2-9483-5AB8A8A44522

Q34979129-42E2CBD3-7196-42D0-B828-ACBD3D8148B0

Q34979129-724C95E3-A0FC-4491-842D-8AB54FD4554F

Q34979129-771C8B2D-C8E7-4C66-834C-5F601EFC1034

Q34979129-A051631D-6248-419B-8E27-8A6BFD5D4818

Q34979129-A350524E-D376-4614-AAE9-269E5A82B259

Q34979129-BB3F09DD-57C5-4E9B-B43F-83B8F4528413

Q34979129-BE06E244-DAFF-43FF-8968-82FCF4568812

Q34979129-F46D7F5E-7049-4CF7-9D59-3DB3FA901F24

P2860

Q34979129-084BF907-81A9-4502-A09C-B3FFBE9AC19D

Q34979129-0878354E-6A38-482C-B76C-16801A0CCAFC

Q34979129-0A71E8CA-029F-4256-9039-446D550EC720

Q34979129-14E2AC5E-E44E-4389-8017-9DFC810FA364

Q34979129-1B84E586-6EFF-4680-BEC1-57614FB8EE04

Q34979129-276C7F99-3F51-45BB-9ABC-B8709C90B876

Q34979129-31707A10-F588-43DE-A8D2-F41CFEF72C64

Q34979129-37065E84-1F7D-40FD-AEE4-F593B4DDFD7A

Q34979129-3E6B2181-D292-4975-8E81-BA616D657D3C

Q34979129-40BAE651-3D7B-41FC-BADB-0F88B6CA3A86

P2888

Q34979129-2960A966-0E89-4911-AA1F-8C111C6E1F07

P304

Q34979129-7059B3D1-5153-48A0-B6D0-676C7E46B198

P31

Q34979129-E3D22F88-AFD3-418E-8032-D4A13B2B9BD5

P356

Q34979129-84E606E2-C54E-4DBD-8D62-16A4B3084376

P478

Q34979129-15BD6E82-78C5-404D-AE8C-526B46A6E7CC

P50

Q34979129-F94447F5-4E16-4287-ACE9-5A2D54966EBF

P577

Q34979129-760DA193-184C-4770-8053-8E1757796026

P5875

Q34979129-67A120EA-5DC3-4CD6-84F8-1E738895EF2E

P6179

Q34979129-7F1C01C1-BD48-48FF-B5E1-68F825EA0379

P698

Q34979129-D86EB18F-2736-40E8-B5DA-B7D3877D3C55

P921

Q34979129-2156ED22-D894-4837-86B2-5760DAB33AFD

P932

Q34979129-F7B20727-8C3B-4C25-8D48-E80B140311DD

P356

S12918-014-0141-Z

P1433

BMC Systems Biology

P1476

Insights from systems pharmacology into cardiovascular drug discovery and therapy

@en

P2093

Aiping Lu

http://www.w3.org/2001/XMLSchema#string

Chao Huang

http://www.w3.org/2001/XMLSchema#string

Chunli Zheng

http://www.w3.org/2001/XMLSchema#string

Jiangfeng Du

http://www.w3.org/2001/XMLSchema#string

Ling Yang

http://www.w3.org/2001/XMLSchema#string

Peng Li

http://www.w3.org/2001/XMLSchema#string

Pidong Li

http://www.w3.org/2001/XMLSchema#string

Xuetong Chen

http://www.w3.org/2001/XMLSchema#string

Yingxue Fu

http://www.w3.org/2001/XMLSchema#string

Yonghua Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Gene-disease network analysis reveals functional modules in mendelian, complex and environmental diseases

A dynamic network approach for the study of human phenotypes

Gene ontology: tool for the unification of biology

Mutation of an A-kinase-anchoring protein causes long-QT syndrome

Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders

DrugBank 3.0: a comprehensive resource for 'omics' research on drugs

The implications of human metabolic network topology for disease comorbidity

The human disease network

Systems pharmacology: network analysis to identify multiscale mechanisms of drug action

Structure and dynamics of molecular networks: a novel paradigm of drug discovery: a comprehensive review

P2888

s12918-014-0141-z

P304

141

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12918-014-0141-Z

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-12-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

270003038

http://www.w3.org/2001/XMLSchema#string

P6179

1027954052

http://www.w3.org/2001/XMLSchema#string

P698

25539592

http://www.w3.org/2001/XMLSchema#string

P921

P932

4297424

http://www.w3.org/2001/XMLSchema#string